SVF Pauling (Cayman) Ltd sold RLAY
August 25, 2026 · Form 4 insider transaction
SVF Pauling (Cayman) Ltd sold 6,000,000 shares of Relay Therapeutics, Inc. at $19.40 per share, a transaction worth $116.40M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. ("AIV M2"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing AIV M2 in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of AIV M2, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF Pauling (Cayman) Limited's investments.